OBJECTIVE: To prospectively monitor levels of proinflammatory cytokines and aggrecan ARGS neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking telopeptide of type II collagen (CTX-II) and N-terminal crosslinking telopeptide of type I collagen (NTX-I) in urine after acute anterior cruciate ligament (ACL) rupture. METHODS: Synovial fluid, serum, and urine were collected from 121 adults on 6 occasions over 5 years after acute ACL injury. Reference samples were obtained from subjects without knee injury. Concentrations of interleukin-6 (IL-6), IL-8, IL-10, interferon-γ (IFNγ), tumor necrosis factor (TNF), aggrecan ARGS neoepitope, CTX-II, and NTX-I were measured by enzyme-linked immunosorbent assay. RESULTS: Shortly after ACL injury, cytokine concentrations in synovial fluid were elevated 6-fold (TNF) to 1,050-fold (IL-6) compared to reference levels, while concentrations of aggrecan ARGS neoepitope in synovial fluid and serum and CTX-II in urine were elevated 1.4-fold to 8-fold. Thereafter, concentrations of cytokines and aggrecan ARGS neoepitope in synovial fluid decreased with different half-lives (in years: IL-6 0.9, IL-8 2.2, IL-10 2.3, IFNγ 3.1, TNF 3.6, aggrecan ARGS neoepitope 4.0). After 5 years, the TNF concentration in synovial fluid remained higher than the reference level. There was a correlation between the concentrations of aggrecan ARGS neoepitope in synovial fluid and serum (rs = 0.36). Concentrations of aggrecan ARGS neoepitope in synovial fluid and of CTX-II and NTX-I in urine were correlated with concentrations of cytokines in synovial fluid (rs = 0.41-0.49 and rs = 0.21-0.31, respectively). CONCLUSION: Acute ACL injury induced highly increased levels of inflammatory cytokines in the joint, and these were associated with proteolysis of aggrecan and type II collagen. Cytokine levels remained increased up to 5 years after injury, indicative of extended local inflammation in the joint.
OBJECTIVE: To prospectively monitor levels of proinflammatory cytokines and aggrecan ARGS neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking telopeptide of type II collagen (CTX-II) and N-terminal crosslinking telopeptide of type I collagen (NTX-I) in urine after acute anterior cruciate ligament (ACL) rupture. METHODS: Synovial fluid, serum, and urine were collected from 121 adults on 6 occasions over 5 years after acute ACL injury. Reference samples were obtained from subjects without knee injury. Concentrations of interleukin-6 (IL-6), IL-8, IL-10, interferon-γ (IFNγ), tumor necrosis factor (TNF), aggrecan ARGS neoepitope, CTX-II, and NTX-I were measured by enzyme-linked immunosorbent assay. RESULTS: Shortly after ACL injury, cytokine concentrations in synovial fluid were elevated 6-fold (TNF) to 1,050-fold (IL-6) compared to reference levels, while concentrations of aggrecan ARGS neoepitope in synovial fluid and serum and CTX-II in urine were elevated 1.4-fold to 8-fold. Thereafter, concentrations of cytokines and aggrecan ARGS neoepitope in synovial fluid decreased with different half-lives (in years: IL-6 0.9, IL-8 2.2, IL-10 2.3, IFNγ 3.1, TNF 3.6, aggrecan ARGS neoepitope 4.0). After 5 years, the TNF concentration in synovial fluid remained higher than the reference level. There was a correlation between the concentrations of aggrecan ARGS neoepitope in synovial fluid and serum (rs = 0.36). Concentrations of aggrecan ARGS neoepitope in synovial fluid and of CTX-II and NTX-I in urine were correlated with concentrations of cytokines in synovial fluid (rs = 0.41-0.49 and rs = 0.21-0.31, respectively). CONCLUSION: Acute ACL injury induced highly increased levels of inflammatory cytokines in the joint, and these were associated with proteolysis of aggrecan and type II collagen. Cytokine levels remained increased up to 5 years after injury, indicative of extended local inflammation in the joint.
Authors: John D King; Grant Rowland; Alejandro G Villasante Tezanos; James Warwick; Virginia B Kraus; Christian Lattermann; Cale A Jacobs Journal: Cartilage Date: 2018-07-22 Impact factor: 4.634
Authors: Hope C Davis; Jeffery T Spang; Richard F Loeser; Staffan Larsson; Veronica Ulici; J Troy Blackburn; R Alexander Creighton; Ganesh M Kamath; Joanne M Jordan; Stephen W Marshall; Brian Pietrosimone Journal: Knee Date: 2018-03-07 Impact factor: 2.199
Authors: A Ruiz; A Duarte; D Bravo; E Ramos Gavilá; C Zhang; M K Cowman; T Kirsch; M Milne; L G Luyt; J G Raya Journal: Osteoarthritis Cartilage Date: 2021-11-11 Impact factor: 6.576
Authors: Armaghan Mahmoudian; L Stefan Lohmander; Ali Mobasheri; Martin Englund; Frank P Luyten Journal: Nat Rev Rheumatol Date: 2021-08-31 Impact factor: 20.543
Authors: Gustavo A Orozco; Atte S A Eskelinen; Joonas P Kosonen; Matthew S Tanaka; Mingrui Yang; Thomas M Link; Benjamin Ma; Xiaojuan Li; Alan J Grodzinsky; Rami K Korhonen; Petri Tanska Journal: J Orthop Res Date: 2021-10-01 Impact factor: 3.102
Authors: André Struglics; Marcin Okroj; Per Swärd; Richard Frobell; Tore Saxne; L Stefan Lohmander; Anna M Blom Journal: Arthritis Res Ther Date: 2016-10-06 Impact factor: 5.156
Authors: Fiona E Watt; Erin Paterson; Andrew Freidin; Mark Kenny; Andrew Judge; Jeremy Saklatvala; Andy Williams; Tonia L Vincent Journal: Arthritis Rheumatol Date: 2016-09 Impact factor: 10.995